vascular hyporeactivity
Recently Published Documents


TOTAL DOCUMENTS

130
(FIVE YEARS 6)

H-INDEX

24
(FIVE YEARS 1)

2022 ◽  
pp. 174757
Author(s):  
Pankaj Yadav ◽  
Hina Iqbal ◽  
Kapil Kumar ◽  
Parmanand Kumar ◽  
Divya Mishra ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Chen Wang ◽  
Hui-Bo Du ◽  
Zhen-Ao Zhao ◽  
Jia-Yi Zhai ◽  
Li-Min Zhang ◽  
...  

Objective: The aim of this study was to clarify the role of autophagy in stellate ganglion block (SGB) reversing posthemorrhagic shock mesenteric lymph (PHSML)-mediated vascular hyporeactivity.Methods: Hemorrhagic shock model in conscious rats was employed to observe the effects of SGB (0.2 ml of 0.25% ropivacaine hydrochloride hydrate) and autophagy inhibitor 3-methyladenine (3-MA; 30 mg/kg) on the vascular reactivity of second-order rat mesenteric arteries in vitro, while the effects of PHSML (1 ml/kg) and autophagy agonist rapamycin (Rapa, 10 mg/kg) on the beneficial effect of SGB were investigated. The cellular viability, contractility, and autophagy-related protein expressions in vascular smooth muscle cells (VSMCs) were detected following treatments of PHSML, PHSML obtained from the rats that underwent hemorrhagic shock plus SGB (PHSML-SGB), and PHSML plus 3-MA (5 mM), respectively.Results: Hemorrhagic shock significantly decreased the vascular reactivity to gradient norepinephrine (NE), which is reversed by the SGB treatment and 3-MA administration. On the contrary, PHSML intravenous infusion and Rapa administration inhibited the vascular contractile responses in rats that underwent hemorrhagic shock plus SGB treatment. PHSML treatment significantly inhibited the cellular viability and contractility in VSMCs, increased the expressions of LC3-II and Beclin 1, and decreased the expression of p62, along with opposite appearances in these indices following PHSML-SGB treatment. In addition, 3-MA counteracted the adverse roles of PHSML in these indices in VSMCs.Conclusion: SGB inhibits PHSML-mediated vascular hyporeactivity by reducing the excessive autophagy in VSMCs.


2020 ◽  
Vol 121 ◽  
pp. 109304
Author(s):  
Hui-ting Di ◽  
Xiao-zhi Wu ◽  
Hong-qian Wang ◽  
Mo Chen ◽  
Er-liang Kong ◽  
...  

2019 ◽  
Vol 87 (6) ◽  
pp. 1346-1353
Author(s):  
HongLiang Zhao ◽  
Lei Kuang ◽  
JiaoJiang He ◽  
ZiSen Zhang ◽  
DanYang Zheng ◽  
...  

2019 ◽  
Vol 28 (1) ◽  
pp. 165-174 ◽  
Author(s):  
Yao-Yao Bai ◽  
Dong Yan ◽  
Hui-Ying Zhou ◽  
Wei-Xin Li ◽  
Yang-Yun Lou ◽  
...  

2018 ◽  
Vol 70 (6) ◽  
pp. 1150-1157 ◽  
Author(s):  
Preeti Singh ◽  
Pranshu Sharma ◽  
Udayraj P. Nakade ◽  
Abhishek Sharma ◽  
Manju Gari ◽  
...  

2018 ◽  
Vol 221 ◽  
pp. 190-195 ◽  
Author(s):  
Tsui-Chin Peng ◽  
Chao-Yuan Chang ◽  
I-Tao Huang ◽  
Ming-Chang Kao ◽  
Ya-Ying Chang ◽  
...  

2017 ◽  
Vol 313 (3) ◽  
pp. C262-C273 ◽  
Author(s):  
Jing Xu ◽  
Guangming Yang ◽  
Tao Li ◽  
Liangming Liu

Angiopoietin-2 (Ang-2) contributes to vascular hyporeactivity after hemorrhagic shock and hypoxia through upregulation of inducible nitric oxide synthase (iNOS) in a vascular endothelial cell (VEC)-specific and Ang-2/Tie2 receptor-dependent manner. While iNOS is primarily expressed in vascular smooth muscle cells (VSMCs), the mechanisms of signal transfer from VECs to VSMCs are unknown. A double-sided coculture model with VECs and VSMCs from Sprague-Dawley rats was used to investigate the role of myoendothelial gap junctions (MEGJs), the connexin (Cx) isoforms involved, and other relevant mechanisms. After hypoxia, VSMCs treated with exogenous Ang-2 showed increased iNOS expression and hyporeactivity, as well as MEGJ formation and communication. These Ang-2 effects were suppressed by the MEGJ inhibitor 18α-glycyrrhetic acid (18-GA), Tie2 siRNA, or Cx43 siRNA. Reagents antagonizing cAMP or protein kinase A (PKA) in VECs inhibited Cx43 expression in MEGJs, decreasing MEGJ formation and associated communication, after hypoxia following Ang-2 treatment. The increased cAMP levels in VSMCs and transfer of Alexa Fluor 488-labeled cAMP from VECs to VSMCs, after hypoxia following Ang-2 treatment, was antagonized by Cx43 siRNA. A cAMP antagonist added to VECs or VSMCs inhibited both increased iNOS expression and hyporeactivity in VSMCs subjected to hypoxia following Ang-2 treatment. Based on these findings, we propose that Cx43 was the Cx isoform involved in MEGJ-mediated VEC-dependent regulation of Ang-2, which induces iNOS protein expression and vascular hyporeactivity after hypoxia. Cx43 was upregulated by cAMP and PKA, permitting cAMP transfer between cells.


2016 ◽  
Vol 94 (8) ◽  
pp. 858-867
Author(s):  
Mustafa Boz ◽  
Pergin Atilla ◽  
Alper B. Iskit ◽  
Mustafa Ilhan

In this study, the possible therapeutic effects of various ATP-sensitive potassium channel (KATP) blockers (glibenclamide, repaglinide, 5-HD, HMR-1098) have been tested in experimental septic shock model. Rats were given lipopolysaccharide (1 mg·kg−1) to create experimental shock model and 4 h later, under 400 mg·kg−1 chloral hydrate anesthesia, parameters such as blood pressure, mesenteric blood flow, the response of mesenteric circulation to phenylephrine (vasoconstrictor stimulation), and organ and oxidative damage were analyzed. Also 75 mg·kg−1 lethal dose of lipopolysaccharide was given to mice and effects of KATP blockers on survival have been tested. Non-selective blocker glibenclamide with sulphonylurea structure and sarcolemmal KATP channel blocker HMR-1098, which have the similar chemical structure, have improved the pathological parameters such as decrease in mesenteric blood flow, vascular hyporeactivity, but could not prevent the decrease in blood pressure, and oxidative and organ damage that were observed in the shock model. Also, both blockers have decreased the mortality rate from 80% to 40%–50%. Similar (preventive) therapeutic effects were not observed with non-selective blocker repaglinide and mitochondrial KATP channel blocker 5-HD, which were non-sulphonylurea structure. As a result, only KATP channel blockers that have sulphonylurea structure can be a new therapeutic approach in septic shock.


Sign in / Sign up

Export Citation Format

Share Document